Response to commentary on “pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors”

Marcio Barcellos; Antonio Braga; Matheus Machado Rech; Solange Artimos de Oliveira; Jose Mauro Madi; Sue Yazaki Sun; Jorge de Rezende-Filho; Kevin M. Elias; Neil S. Horowitz; Ross S. Berkowitz

doi:10.1590/

Response to commentary on “pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors”

Authors

Marcio Barcellos Universidade Federal Fluminense, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil https://orcid.org/0009-0009-1547-6689
Antonio Braga Universidade Federal Fluminense, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil
Matheus Machado Rech Universidade de Caxias do Sul, Faculdade de Medicina, Caxias do Sul, RS, Brazil https://orcid.org/0000-0002-2961-9443
Solange Artimos de Oliveira Universidade Federal Fluminense, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil https://orcid.org/0000-0002-1862-2348
Jose Mauro Madi Universidade de Caxias do Sul, Faculdade de Medicina, Caxias do Sul, RS, Brazil https://orcid.org/0000-0002-2345-4713
Sue Yazaki Sun Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, SP, Brazil https://orcid.org/0000-0001-6573-7386
Jorge de Rezende-Filho Universidade Federal do Rio de Janeiro, Maternidade Escola, Rio de Janeiro, RJ, Brazil https://orcid.org/0000-0002-2193-3374
Kevin M. Elias Harvard University, Harvard Medical School, Boston, MA, USA https://orcid.org/0000-0003-1502-5553
Neil S. Horowitz Harvard University, Harvard Medical School, Boston, MA, USA
Ross S. Berkowitz Harvard University, Harvard Medical School, Boston, MA, USA

DOI:

https://doi.org/10.1590/

Abstract

Dear editor,
We appreciate the thoughtful commentary by the authors1 regarding our systematic review and meta-analysis on pembrolizumab in Gestational Trophoblastic Neoplasia (GTN).2 Their constructive feedback underscores important methodological considerations that warrant further discussion.

Downloads

Download data is not yet available.

Downloads

Published

2025-01-27

Issue

Vol. 80 (2025)

Section

Letters

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Barcellos, M., Braga, A., Rech, M. M., Oliveira, S. A. de, Madi, J. M., Sun, S. Y., Rezende-Filho, J. de, Elias, K. M., Horowitz, N. S., & Berkowitz, R. S. (2025). Response to commentary on “pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors”. Clinics, 80, 100713. https://doi.org/10.1590/

Download Citation

Response to commentary on “pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors”

Authors

DOI:

Abstract

Downloads

Downloads

Published

Issue

Section

License

How to Cite

Language